<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR170.html">Part 170
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 170.101  Information in a premarket notification for a food
                            </h3>
                            <p class="depth0">An FCN must contain the following:</p><p class="depth1"><em>(a)</em> A comprehensive discussion of the basis for the manufacturer's  or supplier's determination that the use of the food contact substance  is safe. This discussion must:</p><p class="depth2"><em>(1)</em> Discuss all information and data submitted in the notification;  and</p><p class="depth2"><em>(2)</em> Address any information and data that may appear to be  inconsistent with the determination that the proposed use of the food  contact substance is safe.</p><p class="depth1"><em>(b)</em> All data and other information that form the basis of the  determination that the food contact substance is safe under the intended  conditions of use. Data must include primary biological data and  chemical data.</p><p class="depth1"><em>(c)</em> A good laboratory practice statement for each nonclinical  laboratory study, as defined under Sec. 58.3(d) of this chapter, that is  submitted as part of the FCN, in the form of either:</p><p class="depth2"><em>(1)</em> A signed statement that the study was conducted in compliance  with the good laboratory practice regulations under part 58 of this  chapter; or</p><p class="depth2"><em>(2)</em> A brief signed statement listing the reason(s) that the study  was not conducted in compliance with part 58 of this chapter.</p><p class="depth2"><em>(3)</em> Data from any study conducted after 1978 but not conducted in  compliance with part 58 of this chapter must be validated by an  independent third party prior to submission to the Food and Drug  Administration (FDA), and the report and signed certification of the  validating party must be submitted as part of the notification.</p><p class="depth1"><em>(d)</em> Information to address FDA's responsibility under the National  Environmental Policy Act, in the form of either:</p><p class="depth2"><em>(1)</em> A claim of categorical exclusion under Sec. 25.30 or Sec. 25.32  of this chapter; or</p><p class="depth2"><em>(2)</em> An environmental assessment complying with Sec. 25.40 of this  chapter.</p><p class="depth1"><em>(e)</em> A completed and signed FDA Form No. 3480.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
